<DOC>
	<DOCNO>NCT01792713</DOCNO>
	<brief_summary>Investigation aim explore efficacy topical Sertaconazole cream 2 % patient skin alteration associate atopic dermatitis</brief_summary>
	<brief_title>Sertaconazole 2 % Cream Improve Symptoms Associated With Atopic Dermatitis</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Sertaconazole</mesh_term>
	<criteria>Informed consent Atopic Dermatitis Patients SCORing Atopic Dermatitis ( SCORAD ) â‰¤ 40 Atopic lesion localisation : arm ; additional leg , neck SCORAD &gt; 40 Unstable , uncontrolled medical status ( e.g . active systemic topical infection ) Active immunosuppression cancer Narcotics Alcohol abuse Participation another clinical trial one month prior inclusion Known allergy ingredient investigational medicinal product Different period grace certain pretreatments , e.g . topical corticosteroid , immune modulate drug Pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Skin alteration</keyword>
	<keyword>Atopic Dermatitis</keyword>
</DOC>